drug

topiramate

1 story · latest Jul 2, 2026

Status: FDA approved Dec 1996 · NDA020505, NDA020844, NDA201635, NDA205122, NDA214679
Brands: Eprontia, Qudexy Xr, Topamax, Trokendi Xr
Trials: 2 registered trials in coverage

Relationships

Developed by Johnson & Johnson

Developed by Supernus Pharmaceuticals, Inc.

Timeline

AbbVie posts TEMPLE Phase 3 results for atogepant vs topiramate; opens three early-stage trials

Jul 2Weekly roundup, 5 itemsABBV-313 AbbVie

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.